Oxiracetam in dementia: a double-blind, placebo-controlled study
- 1 September 1992
- journal article
- clinical trial
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 86 (3) , 237-241
Abstract
A multicentre, double-blind, between-patient study was carried out to evaluate the efficacy and tolerability of oxiracetam (800 mg tablet), in comparison with placebo, each given twice daily for 12 weeks to patients suffering from primary degenerative, multi-infarct or mixed dementia. Efficacy was assessed by a neuropsychological battery (simple reaction time, controlled associations, short story, Raven's Progressive Matrices, token test, digit span, word list learning), administered at the beginning and at the end of the study, and by a quality of life scale, administered at entry and after 6 and 12 weeks treatment. Sixty-five patients (28 men, 37 women, mean age 71 yrs) were enrolled; 58 completed the study: 2 on oxiracetam were withdrawn because of poor tolerability, 2 (one in each group) were withdrawn for poor compliance, one (on oxiracetam) for the occurrence of a transient ischaemic attack (defined as not related to the treatment) and 2 for administrative reasons. A significantly (p < 0.01) different effect in favour of oxiracetam was observed on the quality of life scale, and confirmed by significant (defined according to the Bonferroni technique) differences in some neuropsychological tests (e.g. controlled associations, short story). Four patients in the oxiracetam group complained of a total of 5 unwanted effects, and 1 on placebo complained of 3 unwanted effects, but none of them was withdrawn from the study.Keywords
This publication has 14 references indexed in Scilit:
- Blockade of the nootropic action of piracetam-like nootropics by adrenalectomy: an effect of dosage?Behavioural Brain Research, 1989
- A double‐blind, placebo‐controlled study with oxiracetam in demented patients administered the Luria‐Nebraska Neuropsychological BatteryDrug Development Research, 1988
- Do piracetam-like compounds act centrally via peripheral mechanisms?Brain Research, 1987
- Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesiaEuropean Journal of Pharmacology, 1986
- Activity of Oxiracetam in Patients with Organic Brain SyndromeClinical Neuropharmacology, 1986
- Effect of Oxiracetam and Piracetam on Central Cholinergic Mechanisms and Active-Avoidance AcquisitionClinical Neuropharmacology, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- EFFECTS OF OXIRACETAM ON THE PERFORMANCE OF AGED RATS IN A ONE-WAY ACTIVE AVOIDANCE SITUATIONClinical Neuropharmacology, 1984
- The Reliability of Reaction Time DeterminationsCortex, 1977
- Cerebral Blood Flow in DementiaArchives of Neurology, 1975